| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | PLX4720 | CTRPv2 | pan-cancer | AAC | 0.25 | 6e-11 |
| mRNA | ciclopirox | CTRPv2 | pan-cancer | AAC | -0.18 | 5e-07 |
| mRNA | dabrafenib | CTRPv2 | pan-cancer | AAC | 0.25 | 2e-06 |
| mRNA | PX-12 | CTRPv2 | pan-cancer | AAC | -0.14 | 1e-05 |
| mRNA | KX2-391 | CTRPv2 | pan-cancer | AAC | -0.16 | 1e-05 |
| mRNA | doxorubicin:navitoclax (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.16 | 2e-05 |
| mRNA | vincristine | CTRPv2 | pan-cancer | AAC | -0.15 | 2e-05 |
| mRNA | SR-II-138A | CTRPv2 | pan-cancer | AAC | -0.15 | 2e-05 |
| mRNA | GDC-0879 | CTRPv2 | pan-cancer | AAC | 0.17 | 3e-05 |
| mRNA | Oxaliplatin | CTRPv2 | pan-cancer | AAC | -0.16 | 3e-05 |